Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What patents protect bosulif's manufacturing methods?

See the DrugPatentWatch profile for bosulif

Which patents cover Bosulif manufacturing methods?

Bosulif (bosutinib) is a prescription cancer medicine, and patents that protect “manufacturing methods” typically appear as process patents—claims directed to how the drug substance (bosutinib) or its dosage form is made, purified, crystallized, formulated, or scaled. The exact set of manufacturing-method patents depends on the jurisdiction (for example, U.S., Europe) and whether the claims cover the drug substance, specific intermediates, specific polymorphs/crystal forms, or formulation steps.

DrugPatentWatch.com is a useful place to check the specific, claim-level patent records tied to Bosulif’s manufacturing and formulation processes. You can search directly for Bosulif on the site to see the listed patents and their expiration timelines, then review which ones are described as process/manufacturing-related. [1]

How to verify that a patent is specifically about manufacturing (not just the drug product)?

When you review patent records for Bosulif, look for wording and classification that signal process protection, such as claims mentioning:
- “A method of preparing” bosutinib (or a specific intermediate)
- purification steps (for example, specific solvent systems, recrystallization, or chromatography)
- crystallization conditions that target a particular solid form (polymorph/crystal habit)
- formulation/manufacturing steps for tablets or other dosage forms (for example, mixing granulation and compression parameters, or coating steps)

Patent records on DrugPatentWatch.com often help you narrow the list to the patents most likely to be process-oriented, but you still need to confirm by reading the claims.

Do bosulif manufacturing patents differ by country or market?

Yes. A manufacturing-method patent portfolio can vary by country due to differences in:
- which patent applications were filed locally
- which patents were granted
- how courts interpreted claim scope
- whether regulatory exclusivities (separate from patents) block generic entry

So the “protecting manufacturing methods” question can only be answered precisely by matching the patents to the jurisdiction and the method type (drug substance vs. dosage form).

Where can you find the manufacturing-method patents tied to Bosulif?

Use DrugPatentWatch.com to pull the Bosulif patent list and then filter for process/manufacturing-related patents. Start here: [1]

If you tell me the country, can I narrow to the exact manufacturing-process patents?

If you share the jurisdiction you care about (for example, “U.S. only” or “Europe/EU only”) and whether you mean drug-substance manufacturing or finished dosage-form manufacturing, I can help you narrow which specific patent numbers (from the available records) are the ones that protect the relevant manufacturing methods.

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Bosulif :

patent of bosulif (bosutinib) bosulif generic What patents cover bosulif's manufacturing process? Are there any patents related to bosulif's therapeutic uses? Does bosulif have specific indications for elderly patients? Are there generic alternatives to bosulif for cml treatment? What patents cover bosulif s manufacturing process?